Recent reports have found that nearly 100 million prescriptions are abandoned by patients each year due to surprise costs. For example, the Journal of Managed Care and Specialty Pharmacy found that Increased cost sharing above $100 was associated with up to 75% abandonment rate for certain specialty drugs. This suggests that cost is a prevailing consideration for patients medication purchasing. I think it's fair to say that none of us want to see patients abandoning necessary prescriptions due to high costs. (00:18–00:29)
CLAIM
Asserts that cost sharing above $100 leads to a 75% abandonment rate for certain specialty drugs.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.
